Efaproxiral (RSR13) plus oxygen breathing increases the therapeutic ratio of carboplatin in EMT6 mouse mammary tumors

Experimental Biology and Medicine

Volumn 231, Issue 3, 2006, Pages 317-321

  Donnelly, Erling T ^a   Liu, Yanfeng ^a   Rockwell, Sara ^a,b  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carboplatin; Efaproxiral; Oxygen delivery; RSR13

Indexed keywords

CARBOPLATIN; EFAPROXIRAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TOXICITY; BREAST TUMOR; CELL SURVIVAL; CLONOGENIC ASSAY; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OXYGEN BREATHING; OXYGEN TENSION; OXYGENATION; TUMOR CELL; TUMOR GROWTH; TUMOR MODEL; TUMOR VOLUME;

ANIMALIA;

EID: 33644688614     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100312     Document Type: Article

References (28)

1. Abraham DJ, Wireko FC, Randad RS, Poyart C, Kister J, Bohn B, Liard JF, Kunert MP. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 31:9141-9149, 1992.
2. Randad RS, Mahran MA, Mehanna AS, Abraham DJ. Allosteric modifiers of hemoglobin, 1: design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. J Med Chem 34:752-757, 1991.
3. Safo MK, Moure CM, Burnett JC, Joshi GS, Abraham DJ. Highresolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector. Protein Sci 10:951-957, 2001.
4. Wireko FC, Kellogg GE, Abraham DJ. Allosteric modifiers of hemoglobin, 2: crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors. J Med Chem 34:758-767, 1991.
5. Amorino GP, Lee H, Holburn GE, Paschal CB, Hercules SK, Shyr Y, Steffen RP, Choy H. Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13. Radiat Res 156:294-300, 2001.
6. Doppenberg EM, Rice MR, Alessandri B, Qian Y, Di X, Bullock R. Reducing hemoglobin oxygen affinity does not increase hydroxyl radicals after acute subdural hematoma in the rat. J Neurotrauma 16:123-133, 1999.
7. Hou H, Khan N, O'Hara JA, Grinberg OY, Dunn JF, Abajian MA, Wilmot CM, Demidenko E, Lu S, Steffen RP, Swartz HM. Increased oxygenation of intracranial tumors by Efaproxyn (efaproxiral), an allosteric hemoglobin modifier, in vivo EPR oximetry study. Int J Radiat Oncol Biol Phys 61:1503-1509, 2005.
8. Hou H, Khan N, O'Hara JA, Grinberg OY, Dunn JF, Abajian MA, Wilmot CM, Makki M, Demidenko E, Lu S, Steffen RP, Swartz HM. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study. Int J Radiat Oncol Biol Phys 59:834-843, 2004.
9. 2 delivery in dog muscle in situ. J Appl Physiol 84:995-1002, 1998.
10. Rockwell S, Kelley M. RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice. Radiat Oncol Invest 6:199-208, 1998.
11. Wahr JA, Gerber M, Venitz J, Baliga N. Allosteric modification of oxygen delivery by hemoglobin. Anesth Analg 92:615-620, 2001.
12. Suh JH. Efaproxiral: a novel radiation sensitiser. Expert Opin Investig Drugs 13:543-550, 2004.
13. Donnelly ET, Kelley M, Rockwell S. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo. Cancer Chemother Pharmacol 53:43-50, 2004.
14. Douple EB, Richmond RC. Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II). Int J Radiat Oncol Biol Phys 5:1369-1372, 1979.
15. Grau C, Overgaard J. Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay. Radiother Oncol 13:301-309, 1988.
16. Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. Br J Cancer 89:2133-2139, 2003.
17. Korbelik M, Skov K. Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiat Res 119:145-156, 1989.
18. Melvik JE, Pettersen EO. Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro. Radiat Res 114:489-499, 1988.
19. Skov KA, Adomat H, Farrell NP, Matthews JB. Assessment of toxicity of bis-platinum complexes in hypoxic and aerobic cells. Anticancer Drug Des 13:207-220, 1998.
20. Stratford IJ, Williamson C, Adams GE. Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radio-sensitization in vitro. Br J Cancer 41:517-522, 1980.
21. Teicher BA, Lazo JS, Sartorelli AC. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41:73-81, 1981.
22. Donnelly ET, Liu Y, Fatunmbi YO, Lee I, Magda D, Rockwell S. Effects of texaphyrins on the oxygenation of EMT6 mouse mammary tumors. Int J Radiat Oncol Biol Phys 58:1570-1576, 2004.
23. Moulder JE, Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10:695-712, 1984.
24. Rockwell S. In vivo-in vitro tumor systems: new models for studying the response of tumours to therapy. Lab Anim Sci 27:831-851, 1977.
25. Rockwell S, Irvin CG, Nierenburg M. Effect of a perfluorochemical emulsion on the development of artificial lung metastases in mice. Clin Exp Metastasis 4:45-50, 1986.
26. Rockwell S, Nierenburg M, Irvin CG. Enhancement of artificial lung metastases by misonidazole. Int J Radiat Oncol Biol Phys 10:1395-1398, 1984.
27. Rockwell S. Perfluorochemical emulsions and radiation therapy. Artif Cells Blood Substitutes and Immobil Biotech 22:1097-1108, 1994.
28. Rockwell S, Nierenburg M, Irvin CG. Effects of the mode of administration of mitomycin on tumor and marrow response and on the therapeutic ratio. Cancer Treat Rep 71:927-934, 1987.